FDA Inspection 863098 — Biomat USA, Inc

Biomat USA, Inc — FEI 1038382

The FDA completed an inspection of Biomat USA, Inc on Jan 16, 2014 in Asheville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 16, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Asheville, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.